Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis - Eisele,B.; Lamy,M.; Thijs,L.G. (Intensive Care Med, 1998)